Table 4 MG related absence from work (AW) in the first year after index in the claims dataset in overall study population and different subgroups.

From: The economic burden of Myasthenia gravis from the patient´s perspective and reflected in German claims data

 

All incident n = 775

No MG-related treatment n = 229

Standard treatment n = 447

Intensified treatment n = 99

EOMG n = 120

LOMG n = 655

Patients included in this analysis (= not retired population), n (%)

260 (33.6)

83 (36.2)

157 (35.1)

20 (20.2)

112 (93.3)

148 (22.6)

Patients with ≥ 1 AW, n (%)

149 (57.3)

29 (34.9)

108 (68.8)

12 (60.0)

63 (56.3)

86 (58.1)

AW/patient-year, n (95% CI)

0.89 (0.77–1.01)

0.38 (0.26–0.54)

1.1 (1.0–1.3)

1.1 (0.7–1.7)

1.0 (0.8–1.2)

0.79 (0.65–0.95)

AW in days/patient-year, n (95% CI)

67.1 (66.1–68.2)

20.8 (19.7–21.8)

79.3 (77.9–80.8)

168.1 (162.0–174.4)

55.2 (53.8–56.6)

76.1 (74.7–77.6)

Back to article page